{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:44:25Z","timestamp":1791895465761,"version":"4.3.4"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1093\/carcin\/bgs142","type":"journal-article","created":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:29:39Z","timestamp":1333240179000},"page":"1187-1192","source":"Crossref","is-referenced-by-count":59,"title":["HIF1\u03b1 regulated expression of XPA contributes to cisplatin resistance in lung cancer"],"prefix":"10.1093","volume":"33","author":[{"given":"Yanbin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Bernauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin M.","family":"Yingling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Belinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,3,31]]},"reference":[{"key":"key\n\t\t\t\t20170521000933_bib1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170521000933_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","article-title":"DNA repair pathways as targets for cancer therapy","volume":"8","author":"Helleday","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20170521000933_bib3","doi-asserted-by":"crossref","first-page":"8949","DOI":"10.1038\/sj.onc.1206096","article-title":"Subpathways of nucleotide excision repair and their regulation","volume":"21","author":"Hanawalt","year":"2002","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170521000933_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2443.1996.d01-252.x","article-title":"Implications of the zinc-finger motif found in the DNA-binding domain of the human XPA protein","volume":"1","author":"Morita","year":"1996","journal-title":"Genes Cells"},{"key":"key\n\t\t\t\t20170521000933_bib5","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1134\/S0006297908080063","article-title":"Interaction of nucleotide excision repair factors XPC-HR23B, XPA, and RPA with damaged DNA","volume":"73","author":"Krasikova","year":"2008","journal-title":"Biochemistry (Mosc.)"},{"key":"key\n\t\t\t\t20170521000933_bib6","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1038\/sj.emboj.7601894","article-title":"Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA","volume":"14","author":"Tsodikov","year":"2007","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20170521000933_bib7","doi-asserted-by":"crossref","first-page":"22991","DOI":"10.1074\/jbc.272.37.22991","article-title":"DNA damage recognition by XPA protein promotes efficient recruitment of transcription factor II H","volume":"272","author":"Nocentini","year":"1997","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170521000933_bib8","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1073\/pnas.91.11.5012","article-title":"Specific association between the human DNA repair proteins XPA and ERCC1","volume":"91","author":"Li","year":"1994","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170521000933_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0027-5107(01)00093-8","article-title":"UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency","volume":"477","author":"Tanaka","year":"2001","journal-title":"Mutat. Res."},{"key":"key\n\t\t\t\t20170521000933_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF01959196","article-title":"Cisplatin: a review of clinical applications and renal toxicity","volume":"7","author":"Sleijfer","year":"1985","journal-title":"Pharm. Weekbl. Sci."},{"key":"key\n\t\t\t\t20170521000933_bib11","first-page":"7107","article-title":"Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary","volume":"266","author":"Johnes","year":"1991","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170521000933_bib12","doi-asserted-by":"crossref","first-page":"15915","DOI":"10.1074\/jbc.270.27.15915","article-title":"Excision repair in mammalian cells","volume":"270","author":"Sancar","year":"1995","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170521000933_bib13","first-page":"5874","article-title":"Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xeroderma pigmentosun group A antisense RNA in human lung adenocarcinoma cells","volume":"9","author":"Wu","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521000933_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bcp.2006.04.025","article-title":"XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair","volume":"72","author":"Cummings","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"key\n\t\t\t\t20170521000933_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-4598-4-18","article-title":"ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines","volume":"4","author":"Weaver","year":"2005","journal-title":"Mol. Cancer"},{"key":"key\n\t\t\t\t20170521000933_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1440-1843.2008.01302.x","article-title":"mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines","volume":"13","author":"Dhimizu","year":"2008","journal-title":"Respirology"},{"key":"key\n\t\t\t\t20170521000933_bib17","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-010-1268-2","article-title":"Resistance to platinum-based chemotherapy in lung cancer cell lines","volume":"66","author":"Chen","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"key\n\t\t\t\t20170521000933_bib18","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1158\/0008-5472.CAN-08-2981","article-title":"Non-small cell lung cancer exhibits transcript overexpression of genes associated with homologous recombination and DNA replication pathways","volume":"69","author":"Saviozzi","year":"2009","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521000933_bib19","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-11-0790","article-title":"Molecular characteristics of ERCC1-negative versus ERCC1-positive tumors in resected NSCLC","volume":"17","author":"Friboulet","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521000933_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.lungcan.2010.05.010","article-title":"The platinum-based treatments for advanced non-small cell lung cancer, is low\/negative ERCC1 expression better than high\/positive ERCC1 expression? A meta-analysis","volume":"70","author":"Chen","year":"2010","journal-title":"Lung Cancer"},{"key":"key\n\t\t\t\t20170521000933_bib21","first-page":"2286","article-title":"Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer","volume":"8","author":"Lord","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521000933_bib22","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1158\/1078-0432.CCR-03-0156","article-title":"Ribonucleotide reductase messenger RNA expression and survival in gemcitabine\/cisplatin-treated advanced non-small cell lung cancer patients","volume":"10","author":"Rosell","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521000933_bib23","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1200\/JCO.2009.21.9766","article-title":"Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer","volume":"27","author":"Reynolds","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170521000933_bib24","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/carcin\/bgp114","article-title":"Concomitant promoter Methylation of multiple genes in lung adenocarcinomas from current, former and never smokers","volume":"30","author":"Tessema","year":"2009","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20170521000933_bib25","first-page":"2370","article-title":"Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers","volume":"62","author":"Belinsky","year":"2002","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521000933_bib26","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1158\/0008-5472.CAN-04-3703","article-title":"Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins","volume":"64","author":"Ramirez","year":"2004","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521000933_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key\n\t\t\t\t20170521000933_bib28","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1093\/nar\/23.23.4878","article-title":"MatInd and matInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data","volume":"23","author":"Quandt","year":"1995","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170521000933_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/blood.V95.1.189","article-title":"Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide","volume":"95","author":"Kimura","year":"2000","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170521000933_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbaexp.2005.03.003","article-title":"MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX","volume":"1729","author":"Kopacek","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20170521000933_bib31","article-title":"SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topotecan via induction of ISG15","author":"Tessema","year":"2011","journal-title":"Oncogene,"},{"key":"key\n\t\t\t\t20170521000933_bib32","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1158\/1078-0432.CCR-10-3026","article-title":"The A\/G allele of Rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinoma","volume":"17","author":"Leng","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521000933_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4614-0332-6_4","article-title":"MicroRNAs as post-transcriptional machines and their interplay with cellular networks","volume":"722","author":"Janga","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"key\n\t\t\t\t20170521000933_bib34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature04871","article-title":"Hypoxia signaling in cancer and approaches to enforcer tumour regression","volume":"441","author":"Pouyssegur","year":"2006","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170521000933_bib35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia\u2014a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20170521000933_bib36","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","article-title":"Regulation of angiogenesis by hypoxia: role of the HIF system","volume":"9","author":"Pugh","year":"2003","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170521000933_bib37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jb\/mvp167","article-title":"Cellular signal transduction of the hypoxia response","volume":"146","author":"Nakayama","year":"2009","journal-title":"J. Biochem."},{"key":"key\n\t\t\t\t20170521000933_bib38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/cvr\/cvq045","article-title":"Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodeling","volume":"86","author":"Rey","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"key\n\t\t\t\t20170521000933_bib39","doi-asserted-by":"crossref","first-page":"32253","DOI":"10.1074\/jbc.271.50.32253","article-title":"Activation of hypoxia-inducible transcription factor depends primarily upon redoxsensitive stabilizaton of its \u03b1 subunit","volume":"271","author":"Huang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170521000933_bib40","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1074\/jbc.M308013200","article-title":"Ras inductiono f superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated osteoblasts","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170521000933_bib41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2011.02.031","article-title":"Noscapine sensitizes chemoresistant ovarian cancer cells to cisplatin through inhibition of HIF-1\u03b1","volume":"305","author":"Su","year":"2011","journal-title":"Cancer Lett."},{"key":"key\n\t\t\t\t20170521000933_bib42","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1158\/1078-0432.CCR-08-3180","article-title":"Identification of a novel small molecule HIF-1alpha translation inhibitor","volume":"25","author":"Narita","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521000933_bib43","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/JTO.0b013e3182417830","article-title":"Hypoxia-inducible factor-1\u03b1 and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy. A retrospective study","volume":"7","author":"Lee","year":"2012","journal-title":"J. Thorac. Oncol."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/33\/6\/1187\/17291401\/bgs142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T04:28:33Z","timestamp":1593923313000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgs142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,31]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,3,31]]},"published-print":{"date-parts":[[2012,6]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgs142","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3,31]]}}}